Calcium Polystyrene Sulfonate


Indications and Reactions:

Role Indications Reactions
Secondary
Hyperkalaemia 16.2%
Ill-defined Disorder 14.7%
Hypertension 11.8%
Hyperphosphataemia 10.3%
Metastatic Renal Cell Carcinoma 8.8%
Cardiovascular Disorder 5.9%
Femur Fracture 5.9%
Renal Cancer Recurrent 5.9%
Acute Myocardial Infarction 4.4%
Drug Use For Unknown Indication 4.4%
Product Used For Unknown Indication 4.4%
Cough 2.9%
Anaemia 1.5%
Constipation 1.5%
Thrombosis Prophylaxis 1.5%
Large Intestine Perforation 12.5%
Blood Creatinine Increased 8.3%
Colon Adenoma 8.3%
Colon Cancer 8.3%
Interstitial Lung Disease 8.3%
Metastases To Liver 8.3%
Peritonitis 8.3%
Pyrexia 8.3%
Abdominal Pain 4.2%
Acute Myocardial Infarction 4.2%
Flank Pain 4.2%
Hypokalaemia 4.2%
Pruritus Generalised 4.2%
Renal Failure Chronic 4.2%
Somnolence 4.2%
Concomitant
Product Used For Unknown Indication 21.5%
Hypertension 21.0%
Prophylaxis 9.0%
Metastatic Renal Cell Carcinoma 5.4%
Hyperkalaemia 4.6%
Rheumatoid Arthritis 3.8%
Diabetes Mellitus 3.4%
Drug Use For Unknown Indication 3.1%
Constipation 2.9%
Supplementation Therapy 2.9%
Type 2 Diabetes Mellitus 2.9%
Cardiac Failure 2.8%
Depression 2.8%
Hyperphosphataemia 2.5%
Renal Failure Chronic 2.4%
Hyperuricaemia 2.1%
Renal Cell Carcinoma 1.8%
Kidney Transplant Rejection 1.8%
Nausea 1.8%
Pancreatitis 1.7%
Blood Potassium Increased 11.4%
Renal Impairment 10.0%
Sepsis 10.0%
Hyperkalaemia 7.9%
Renal Failure 7.1%
Pneumonia 5.7%
Renal Failure Acute 5.7%
Rhabdomyolysis 5.0%
Peritonitis 4.3%
Pyrexia 4.3%
Renal Failure Chronic 4.3%
Sigmoiditis 3.6%
Chest Discomfort 2.9%
Platelet Count Decreased 2.9%
Pulmonary Oedema 2.9%
Vomiting 2.9%
White Blood Cell Count Decreased 2.9%
Acute Myocardial Infarction 2.1%
Agranulocytosis 2.1%
Anaemia 2.1%

Drug Data